The Major Constituent of Green Tea, Epigallocatechin-3-Gallate (EGCG), Inhibits the Growth of HPV18-Infected Keratinocytes by Stimulating Proteasomal Turnover of the E6 and E7 Oncoproteins

Sinecatechins ointment as a potential novel treatment for usual type vulval intraepithelial neoplasia: a single center double‐blind randomised control study

(2020) Jason Yap et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

mRNA sequencing of novel cell lines from human papillomavirus type-16 related vulval intraepithelial neoplasia: Consequences of expression of HPV16 E4 and E5

(2014) Dean Bryant et al.   JOURNAL OF MEDICAL VIROLOGY

Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial

(2014) Amanda Tristram et al.   LANCET ONCOLOGY

Effect of HPV Assay Choice on Perceived Prevalence in a Population-based Sample

(2013) Kate Cuschieri et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia

(2013) Mathias K. Fehr et al.   Journal of Gynecologic Oncology

The Role of Protein Kinase A Regulation of the E6 PDZ-Binding Domain during the Differentiation-Dependent Life Cycle of Human Papillomavirus Type 18

(2013) C. P. Delury et al.   JOURNAL OF VIROLOGY

The E4 protein; structure, function and patterns of expression

(2013) John Doorbar   VIROLOGY

Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea

(2012) J Steinmann et al.   BRITISH JOURNAL OF PHARMACOLOGY

(-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells

(2011) S. R. Choudhury et al.   CARCINOGENESIS

(-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells

(2011) V. Nandakumar et al.   CARCINOGENESIS

In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978–2007—a nationwide population-based study

(2011) L. Baandrup et al.   GYNECOLOGIC ONCOLOGY

Cancer prevention by tea: Evidence from laboratory studies

(2011) Chung S. Yang et al.   PHARMACOLOGICAL RESEARCH

Green Tea Compound in Chemoprevention of Cervical Cancer

(2010) Changping Zou et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: a systematic review and meta-analysis

(2010) TG Tzellos et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells

(2009) Yanyan Qiao et al.   ARCHIVES OF PHARMACAL RESEARCH

The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival

(2009) S. Balasubramanian et al.   CARCINOGENESIS

Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols

(2009) Madhulika Singh et al.   INVESTIGATIONAL NEW DRUGS

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis

(2008) Hugo De Vuyst et al.   INTERNATIONAL JOURNAL OF CANCER

Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod

(2008) Manon van Seters et al.   NEW ENGLAND JOURNAL OF MEDICINE

HIF-1α controls keratinocyte proliferation by up-regulating p21(WAF1/Cip1)

(2007) Young-Suk Cho et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH